http://www.maunakeatech.com/ Wed, 22 May 2013 05:04:06 +0100 http://www.maunakeatech.com/sites/all/themes/mkt/image/site/logo.jpg http://www.maunakeatech.com/ BRONX AGENCE http://www.maunakeatech.com/mktlive/events http://www.maunakeatech.com/mktlive/events Wed, 10 Apr 2013 16:18:49 +0100 The World Molecular Imaging Congress is organized by the joint efforts of the “World Molecular Imaging Society – WMIS“, the “European Society for Molecular Imaging – ESMI” and the “Federation of Asian Societies for Molecular Imaging – FASMI“. The WMIC is led by the senior academic and industry professionals who have widely recognized expertise in molecular imaging. The scientific sessions held at the conference cover a broad spectrum of basic and translational sciences (pre-clinical to clinical) forming a Discovery-to-Delivery (D2D) process that helps facilitate academic and industrial partnerships. Through innovation, our goal is to optimize the D2D efforts leading to new medical and molecular imaging discoveries, greater linkages between research and market outcomes, and significant improvements in healthcare. Comme visit us and discover Cellvizio Dual Band for translational research!

]]> http://www.maunakeatech.com/mktlive/events http://www.maunakeatech.com/mktlive/events Mon, 08 Apr 2013 14:33:04 +0100 The BSG Annual Meeting will take place this year at the Scottish Exhibition and Conference Centre (SECC), Glasgow from the 24th to 27th June 2013. We hope that you will be able to be a part of this multidisciplinary meeting covering all aspects of medical and surgical gastroenterology and hepatology with cutting edge clinical and basic science research.

]]> http://www.maunakeatech.com/mktlive/events http://www.maunakeatech.com/mktlive/events Mon, 08 Apr 2013 14:22:21 +0100 Started in 1983 and held every year in June, this meeting has become established as one of the largest European Workshops in its field, gathering around 820 participants coming from 60 different countries worldwide.

]]> http://www.maunakeatech.com/mktlive/events http://www.maunakeatech.com/mktlive/events Mon, 08 Apr 2013 14:04:56 +0100 Digestive Disease Week® (DDW) is the world's leading educational forum for academicians, clinicians, researchers, students and trainees working in gastroenterology, hepatology, GI endoscopy, gastrointestinal surgery and related fields.

]]> http://www.maunakeatech.com/mktlive/training http://www.maunakeatech.com/mktlive/training Thu, 11 Apr 2013 16:31:01 +0100 Learn how Optical Biopsy will improve your practice, understand how Cellvizio system works, Achieve a basic understanding of Cellvizio image interpretation,observe live cases and review case studies.

]]> http://www.maunakeatech.com/mktlive/newsletter http://www.maunakeatech.com/mktlive/newsletter Tue, 07 May 2013 09:58:58 +0100 http://www.maunakeatech.com/mktlive/press-releases http://www.maunakeatech.com/mktlive/press-releases Tue, 30 Apr 2013 10:10:14 +0100 PARIS, April 30, 2013 – Mauna Kea Technologies (NYSE Euronext: MKEA, FR0010609263), leader in the optical biopsy market and developer of Cellvizio®, the fastest way to see cancer, today announced that the U.S. Food and Drug Administration (FDA) has cleared the AQ-­â€FlexTM 19 miniprobe to provide real-­â€time optical biopsies during endoscopic ultrasound-­â€guided fine needle aspiration (EUSFNA) procedures in the digestive tract. This represents the sixth U.S. regulatory clearance for Mauna Kea Technologies’ Cellvizio or one of its dedicated miniprobes, which already obtained the CE mark in Europe.

]]> http://www.maunakeatech.com/mktlive/events http://www.maunakeatech.com/mktlive/events Fri, 15 Mar 2013 11:38:49 +0100 Chaired by Dr. Marc Giovannini, the 10th European Congress of Endoscopic ultrasonography will take place in Paris from 25 to 26 April 2013. The local and invited guest faculty includes internationally recognized experts in endoscopic ultrasonography. New EUS guided therapies will be demonstrated from Marseille (Paoli-Calmettes Institute), but also new diagnostic technique using needle-based confocal laser endomicroscopy (nCLE).

]]> http://www.maunakeatech.com/mktlive/events http://www.maunakeatech.com/mktlive/events Wed, 10 Apr 2013 17:52:28 +0100 As in previous years, this high-level meeting will foster the strong network of the (European) Molecular Imaging Community. EMIM 2013 will bring together top scientists from various disciplines, working in diverse fields of Molecular Imaging, provide a platform for knowledge exchange between the disciplines, "generations", and societies, strengthen the interaction between the groups and everybody who is sharing our vision that interdisciplinary knowledge exchange is the basis for innovation...
 

]]> http://www.maunakeatech.com/mktlive/events http://www.maunakeatech.com/mktlive/events Mon, 17 Dec 2012 17:17:59 +0100 This course will provide the latest innovations in the management of gastrointestinal diseases and disorders, and a unique opportunity to learn more about the latest interventional and surgical procedures, featuring hands-on animal tissue labs allowing for safe practice.

]]> http://www.maunakeatech.com/mktlive/press-releases http://www.maunakeatech.com/mktlive/press-releases Tue, 23 Apr 2013 17:44:41 +0100 http://www.maunakeatech.com/mktlive/events http://www.maunakeatech.com/mktlive/events Mon, 18 Mar 2013 16:29:59 +0100 The field of endoscopy has rapidly evolved with the introduction of innovative diagnostic techniques and novel therapies. The endoscopist frequently encounters difficult issues and controversies in patient management. This program is designed to take a case-based and endoscopic video approach to understand the current role of endoscopy in the care of patients with a variety of gastrointestinal diseases.

]]> http://www.maunakeatech.com/mktlive/press-releases http://www.maunakeatech.com/mktlive/press-releases Wed, 17 Apr 2013 09:45:10 +0100 http://www.maunakeatech.com/mktlive/events http://www.maunakeatech.com/mktlive/events Tue, 26 Mar 2013 16:58:03 +0100 The field of endoscopy has burgeoned from the ability to simply look at the lining of the GI tract with the scope to the current advanced technology which not only allows interventional gastroenterologists to obtain detailed images but also use the scope as a tool for treatment. Visualization has gone beyond looking at the surface and delved deeper to obtain ultrasound and microscopic images. Diagnostic capabilities have improved to allow for tissue acquisition in challenging anatomy with ERCP, cholangiopancreatoscopy, EUS, and double balloon endoscopy. Surgeons and oncologists increasingly rely on interventional gastroenterologists for appropriate diagnosis, staging and often management of GI neoplasms. Endoscopy has emerged as a less invasive alternative to surgery in the areas of endoscopic mucosal resection, tissue ablation, pancreatic pseudocyst drainage, and now even achalasia therapy. All of these new frontiers of endoscopy are rapidly evolving. This course will outline where standard practices in endoscopy are currently and how new innovations may enhance or revolutionize endoscopic practice in the future.

]]> http://www.maunakeatech.com/mktlive/press-releases http://www.maunakeatech.com/mktlive/press-releases Thu, 11 Apr 2013 17:22:13 +0100 PARIS (April 10, 2013) – Mauna Kea Technologies (NYSE Euronext: MKEA), leader in the optical biopsy market and developer of Cellvizio®, the fastest way to see cancer, announced today that the first Cellvizio system was sold in China, one of the fastest growing, largest medical device markets in the world. Yan-Qing Li, MD, Professor of Gastroenterology at Shandong University, Qilu Hospital, a pioneer in the optical biopsy field in China and a prolific researcher on applications of endomicroscopy, will be a key resource for the education efforts in China.

]]> http://www.maunakeatech.com/mktlive/press-releases http://www.maunakeatech.com/mktlive/press-releases Tue, 26 Mar 2013 17:54:48 +0100 http://www.maunakeatech.com/mktlive/press-releases http://www.maunakeatech.com/mktlive/press-releases Tue, 26 Mar 2013 16:45:07 +0100 PARIS (March 21, 2013) – Mauna Kea Technologies (NYSE Euronext: MKEA), leader in the optical biopsy market and developer of Cellvizio®, the fastest way to see cancer, announced today that it has launched a registry study to determine the impact of Cellvizio optical biopsies on the diagnosis of lung cancer, the leading cause of cancer death in the world. Previous studies have shown that Cellvizio’s real-time, cellular-level views of distal lung tissue extend the reach and improve the diagnostic accuracy of bronchoscopy procedures, reducing the need to repeat invasive, expensive diagnostic tests.

]]> http://www.maunakeatech.com/mktlive/events http://www.maunakeatech.com/mktlive/events Tue, 15 Jan 2013 09:47:54 +0100 http://www.maunakeatech.com/mktlive/events http://www.maunakeatech.com/mktlive/events Thu, 13 Dec 2012 16:29:48 +0100 A French-speaking congress of reference in terms of digestive cancers and diseases gathering 4000 participants each year.

]]> http://www.maunakeatech.com/mktlive/events http://www.maunakeatech.com/mktlive/events Thu, 13 Dec 2012 16:24:27 +0100 The annual Congress of the Federation of the Italian Societies of Digestive Diseases will focus on new techniques in the diagnosis and treatment of digestive diseases.

]]> http://www.maunakeatech.com/mktlive/events http://www.maunakeatech.com/mktlive/events Mon, 11 Mar 2013 12:46:16 +0100 Prof. Maurizio Brausi cordially invites you to discover why Cellvizio® is the Fastest Way to See Urinary Cancers. Join us at the Museo Nazionale della Scienza e della Tecnologia "Leonardo Da Vinci" in Milan.

]]> http://www.maunakeatech.com/mktlive/press-releases http://www.maunakeatech.com/mktlive/press-releases Fri, 15 Mar 2013 14:39:15 +0100 PARIS (March 14, 2013) – Mauna Kea Technologies (NYSE Euronext: MKEA), leader in the optical biopsy market and developer of Cellvizio®, the fastest way to see cancer, reported a new study showing that a Cellvizio optical biopsy can overcome the limitations of standard tissue biopsies in accurately diagnosing cancerous stomach tumors. The study was completed at the Soonchunhyang University Hospital Gastrointestinal Cancer Center in Seoul, Korea. The study findingsi were published online in the March Issue of Gastrointestinal Endoscopy.

]]> http://www.maunakeatech.com/mktlive/events http://www.maunakeatech.com/mktlive/events Thu, 13 Dec 2012 16:08:36 +0100 http://www.maunakeatech.com/mktlive/newsletter http://www.maunakeatech.com/mktlive/newsletter Thu, 28 Feb 2013 11:43:09 +0100 http://www.maunakeatech.com/mktlive/events http://www.maunakeatech.com/mktlive/events Thu, 13 Dec 2012 15:59:04 +0100 Join us for a showcase of the cutting edge in endoscopy. The two day format includes live demonstrations, didactic lectures, and hands-on lab teaching of advanced endoscopic techniques by nationally and internationally recognized faculty.

]]> http://www.maunakeatech.com/mktlive/events http://www.maunakeatech.com/mktlive/events Thu, 13 Dec 2012 15:39:47 +0100 This symposium brings together gastroenterologists, oncologists, internists, surgeons, interventional radiologists, nurses, residents, students and Industry. Cellvizio®, the fastest way to see cancer, will be presented at the exhibition and in live demonstrations. Simultaneous translation will be provided for the following languages: German, English, and Russian

]]> http://www.maunakeatech.com/mktlive/press-releases http://www.maunakeatech.com/mktlive/press-releases Wed, 30 Jan 2013 09:47:08 +0100 Physicians at prestigious Schools of Medicine in Japan, including the Hirosaki University Graduate School of Medicine in Aomori, have acquired Cellvizio systems to gain new understanding of stomach, pancreatic and esophageal cancers, as well as common functional gastrointestinal and motility disorders such as irritable bowel syndrome (IBS), gastro-­â€esophageal reflux disease (GERD) and chronic constipation. Stomach cancer is second most prevalent kind of cancer in Asia and the leading cause of cancer in men in the region, according to the World Health Organization. An estimated 736,000 people die from stomach cancer each year, making it the second leading cause of cancer death worldwide.

]]> http://www.maunakeatech.com/mktlive/news http://www.maunakeatech.com/mktlive/news Wed, 30 Jan 2013 10:27:56 +0100 St. Anthony Hospital is the first hospital in Colorado to use the new advanced-imaging technology, called Cellvizio, with at-risk patients during standard endoscopy and colonoscopy procedures as well as the pancreatic and bile duct cancer detection procedure. Cellvizio allows physicians to view internal tissues cell-by-cell to pinpoint cancerous and pre-cancerous tissue more efficiently than current procedures. Dr. Matt Reveille says the new technology helps doctors respond once they identify dangerous tissue.

]]> http://www.maunakeatech.com/mktlive/events http://www.maunakeatech.com/mktlive/events Mon, 17 Dec 2012 17:12:57 +0100 http://www.maunakeatech.com/mktlive/press-releases http://www.maunakeatech.com/mktlive/press-releases Tue, 15 Jan 2013 15:06:38 +0100 Mauna Kea Technologies, leader in the optical biopsy market and developer of Cellvizio®, the fastest way to see cancer, announced its sales results for the fourth quarter and full year 2012. Fourth quarter sales rose 55% to a record €3.222 million, bringing full year sales to €8.809 million, a 76% increase over 2011 levels.

]]>